Series C Funded Startups in Switzerland
Across the 26 most recent Swiss Series C rounds shown, the largest disclosed amount is SEBA Bank’s $120M (2022-01-12), which sits well above the rest of th…
Across the 26 most recent Swiss Series C rounds shown, the largest disclosed amount is SEBA Bank’s $120M (2022-01-12), which sits well above the rest of the disclosed rounds—several other large entries are in the $90M–$95M range (Monte Rosa Therapeutics $95M on 2021-03-12; CeQur $115M on 2021-04-13), but few disclosed rounds exceed that tier. At the smaller end, Nanolive’s $2M (2022-09-20) is a clear low outlier among disclosed amounts.
The dataset also clusters by time and sector: most rounds fall between March 2021 and September 2025, with a notable acceleration in 2024 (e.g., H55 $73M on 2024-07-24; Alpian $84M on 2024-05-08; xFarm Technologies $40M on 2024-10-09) and continuing into 2025 (CUTISS $39M on 2025-09-14; Numab $55M on 2025-01-09). Biotech appears repeatedly across this page (multiple separate companies such as Numab $55M on 2025-01-09, Nouscom $72M on 2023-11-14, and Monte Rosa Therapeutics $95M on 2021-03-12), and multiple rounds are undisclosed: 3 entries list “undisclosed” amounts (Flyability on 2023-03-03; uniqFEED on 2022-10-25; CUTISS’s or other?), making undisclosed sizing a recurring data-quality constraint.
Most recent rounds
26 shownRelated listings
Frequently asked
What are the largest and smallest disclosed Series C rounds in this Swiss list, and how extreme are they?
The largest disclosed round is SEBA Bank at $120M (2022-01-12), followed by CeQur at $115M (2021-04-13) and Monte Rosa Therapeutics at $95M (2021-03-12). The smallest disclosed round is Nanolive at $2M (2022-09-20), far below the rest of the disclosed amounts.
Do the most recent rounds cluster tightly in time, especially into 2024–2025?
Yes: 2024 includes multiple large and mid-sized disclosed rounds—Alpian $84M (2024-05-08), H55 $73M (2024-07-24), and xFarm Technologies $40M (2024-10-09)—and 2025 continues with CUTISS $39M (2025-09-14), Numab $55M (2025-01-09), and Meteomatics $22M (2025-01-29).
Are specific sectors over-represented in this Series C sample?
Biotechnology is repeatedly represented across different years and cities, including Numab $55M (2025-01-09), ImmunOs Therapeutics $11M (2024-09-17), Nouscom $72M (2023-11-14), and Monte Rosa Therapeutics $95M (2021-03-12). Energy also shows up multiple times (e.g., Synhelion $24M on 2022-12-15; Pexapark $21M on 2023-09-26; Synhelion $24M).
Which entries are timing outliers in terms of disclosure and disclosed-vs-undisclosed amounts?
Three rounds are not sized in USD (“undisclosed”): Flyability on 2023-03-03, uniqFEED on 2022-10-25, and (undisclosed amounts are present elsewhere on the page as shown). Among the disclosed rounds, the Nanolive $2M (2022-09-20) entry is the most striking low-disclosure outlier.
Which city appears most often, and does it coincide with many of the largest rounds?
Zürich is the most frequent city on the page, appearing with companies such as CUTISS (Zürich, 2025-09-14, $39M), Beekeeper (2022-11-09, $50M), and SkyCell (2021-10-11, $35M). The largest disclosed round (SEBA Bank $120M on 2022-01-12) is in Zug, rather than Zürich, indicating Züricʰ is common but not the location of the single biggest disclosed deal.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.